logo
episode-header-image
Jul 2023
41m 17s

AI and Ozempic: The two great disruptive...

Fast Company
About this episode
AI is poised to upend the music industry, and Fast Company Associate Editor David Salazar joins us to discuss what AI generative music is and how the music industry is combating it. Antidiabetic medication Ozempic is all over the news these days, but it's not as new as it seems. Beyond the TikTok trends and celebrity shout-outs, it's been used to treat diabe ... Show More
Up next
Jan 2025
Teflon Son? How Softbank CEO Masayoshi Son’s legend keeps growing
On today’s episode, host Josh Christensen is joined by ‘Fast Company’ associate editor David Salazar to help break down the latest news in the world of business and innovation, including the fallout from DeepSeek’s LLM launch, the backtracked federal funding freeze, and the risin ... Show More
1 h
Jan 2025
Police departments are embracing AI-enhanced surveillance technology to stop crime
Police departments across the country are embracing AI-enhanced surveillance technology in the name of stopping crime. One prominent security firm called Flock Safety is leading the effort and profiting off our fears. Fast Company Senior Writer Ainsley Harris joined Yaz and Josh ... Show More
54m 4s
Dec 2024
Why the NFL, Universal Pictures, and erotic audio company Quinn made our Brands That Matter list
On today’s episode, Yaz and Josh are joined by ‘Fast Company’ senior staff editor Jeff Beer and ‘Fast Company’ associate editor David Salazar to discuss the annual Brands That Matter list. This year, the list includes not just such companies as Athletic Brewing, Quinn Erotic Audi ... Show More
1h 9m
Recommended Episodes
Jul 2023
How Drugs Like Ozempic Are Changing What We Think About Weight Loss
You may have heard about Ozempic, Wegovy and Mounjaro. It’s tough to miss the online chatter, the ads on TV and all the news coverage. They are part of a class of drugs originally designed to treat diabetes, and all three have been shown to help people lose significant amounts of ... Show More
28m 5s
Oct 2023
Semaglutide: Decoding the hype around the weight loss wonder drug
<p>From Elon Musk to several Hollywood celebrities, the weight loss wonder drug, semaglutide, is taking the world by storm. What was an unintended consequence of a diabetes control med, the emergence of significant weight loss has raised the expectation of the wonder drug becomin ... Show More
32m 7s
Dec 2024
068 | The weight is over: How GLP-1 treatments are reshaping pharma and beyond
Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ... Show More
11m 16s
Oct 2023
Ozempic’s Success Is Bad News for Rivals
Bloomberg News Health Reporter Madison Muller discusses how the drug Ozempic could cut demand for big-money drugs targeting a wide range of maladies, even Alzheimer’s. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.See omnystudio.com/listener for privacy information ... Show More
7m 10s
Oct 2023
Congress in Chaos, The Ozempic Effect, and the Healthcare Strike
Kara and Scott discuss declining social media traffic to news sites, Amazon using an algorithm to test how high they could boost prices, and why the boom in weight loss drugs is the “biggest business story of the year.” Also, Kevin McCarthy’s historic ouster marks another predict ... Show More
1h 4m
Aug 2024
AI-Powered Weapons Startup Raises $1.5B & Mounjaro Soars Past Wegovy
Episode 384: Neal and Toby chat about the round of funding for a startup that could transform the landscape of warfare by combining tech and military manufacturing. Then, upheaval in Bangladesh has global economies nervous about its impacts, especially in the fashion industry. Ne ... Show More
28m 8s
Jun 2024
The weight-loss drug revolution
Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of ... Show More
17m 28s
Sep 2023
After Ozempic
Ozempic and other drugs like it are being heralded as game changers for weight loss. Radio Atlantic host Hanna Rosin talks to Atlantic staff writer Olga Khazan about what it means that this medical intervention has arrived at a time when our society seems to be easing away from f ... Show More
24m 15s
Apr 2023
🏋️ “A slimdown in a syringe” — Weight Watchers’ Ozempic win. Rihanna’s perfume power. Tax Day’s big battle.
The latest fad diet isn’t a diet, it’s a shot — Ozempic is being called a miracle weight loss drug, and it’s disrupting Weight Watchers. LVMH is proud of their pricey perfume, and they are selling more than ever thanks to their Rihanna-aided storytelling. And H&R Block vs. TurboT ... Show More
22m 14s